| Literature DB >> 35965316 |
Xinying Wu1,2,3, Wen Cai4, Pengcheng Zhu1,4, Zheng Peng1,2, Tianfei Zheng1,2, Dongliang Li4, Jianghua Li1,2, Guanyu Zhou1,2, Guocheng Du5,6, Juan Zhang7,8.
Abstract
BACKGROUND: The aging process in the tobacco production, as in other food industries, is an important process for improving the quality of raw materials. In the spontaneous aging, the complex components in flue-cured tobacco (FT) improve flavor or reduce harmful compounds through chemical reactions, microbial metabolism, and enzymatic catalysis. Some believed that tobacco-microbe played a significant part in this process. However, little information is available on how microbes mediate chemical composition to improve the quality of FT, which will lay the foundation for the time-consuming spontaneous aging to seek ways to shorten the aging cycle.Entities:
Keywords: Aging process; Flue-cured tobacco; Metabolome; Microbiome; Multi-omics integrated analysis; Quality improvement
Mesh:
Substances:
Year: 2022 PMID: 35965316 PMCID: PMC9377114 DOI: 10.1186/s12866-022-02597-9
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 4.465
Fig. 1Differential analysis between the quality evaluation and DCs of UAFT and AFT samples. a radar map of quality traits. b scatter plot of the quality traits and the classification of DCs based on OPLS-DA model. ARO, aromatic compounds; ALO, alkanes and olefins; ORC, organic acid; AMA, amino acid; HET, heterocycle; POL, polyphenol; ALK, alkaloid; AMI, amine; EST, Esters and lactones; ALC, alcohol; CAR, carbonyl compounds; SUG, sugar; GLY, glycosides; QE, quality evaluation
Fig. 2Scheme of the metabolic pathways involved in the changes of the selected DCs after aging. Italics and different color words are metabolic pathway names; Red stars represent compounds with up-regulated content; Green stars represent compounds with down-regulated content; Green dotted area is the same class of compounds
Fig. 3Bacterial (a) and fungal (b) diversity analysis in UAFT and AFT samples
Fig. 4Comparison of function modules between UAFT and AFT in the level 3 MetaCyc pathway. a bacterial function modules; b fungal function modules
Fig. 5Correlation analysis between the dominant genera and significant DCs between the UAFT and AFT samples. The rounded nodes represent the genera and the square nodes represent DCs. The orange line is a positive correlation, and the blue line is a negative correlation. B2, Stenotrophomonas; B3, Pseudomonas; B4, Acinetobacter; B6, unclassified_Enterobacteriaceae; B15, Sphingomonas; B19, Ochrobactrum; B22, Caulobacter; B28, Vibrionimonas; F1, Sampaiozyma; F2, Aspergillus; F3, Alternaria; F7, Didymella; F8, Epicoccum; F10, Boeremia; B30, Bacteroides. Flavonoids: L475, proacacipetalin; L540, flazine; L608, isoscopoletin; L617, kaempferol-3-O-hexoxyl-hexoside; L660, mahaleboside; L795, dihydropanaxacol; L861, quercetin; G596, caffeic acid; G959, chlorogenic acid; L401, artemisene. Terpenoids and degradation products: L525, erogorgiaene; S88, dihydroactinidiolide; S95, megastigmatrienone A; S96, safranal; S109, β-Cyclocitral; S115, megastigmatrienone B; S144, linalool; S127, trans-geranylgeraniol; S153, 3-hydroxy-β-damascone; S208, limonene. Fatty acids, esters and relatives: L10, isostearic acid; L11, ( +)-myrtenyl formate; L188, 2E,8E-dodecadienoic acid; L262, y-linolenic acid; L684, muramic acid; L740, n-propyl carbamate; L830, picrasin; G195, glycerol; G234, glycerate; G562, palmitic acid; S85, 2-methyl-5-oxotetrahydrofuran-2-carboxylic acid; S86, dodecane; S97, propanoic acid butyl ester; S121, benzeneacetic acid methyl ester; S130, hexanoic acid methyl ester; S165, 2,8-methyl undecane; S185, 3-methyl pentadecane; S206, 4-methyl-nonane; S207, 3-methyl undecane. Aromatic compounds: L231, 3-amino-2-naphthoic acid; L376, alpha-methylphenylalanine; S21, 2-methyl-benzaldehyde; S90, benzeneacetaldehyd; S129, 1-phenyl-ethenone; S154, 2,4-dimethyl-benzaldehyde; S156, 1,2,3,4-tetrahydro-5,6,7,8-tetramethyl-Naphthalene; S161, 2,2',5,5'-tetramethyl-1,1'-Biphenyl; S180, α-ethylidene-benzeneacetaldehyde. Nicotine and degradation products: L4, nicotine; L218, 3,6-dihydronicotinic acid; L388, anatabine; L457, cotinine; L736, nornicotine; S72, 3-(1-methyl-1H-pyrrol-2-yl)- pyridine. Others: L134, 1-Naphthylamine; L138, glycerol phosphate choline; L140, 2-Aminoethyl indole; L202, 2-Methylindole; L254, 3'-Sialyllactose; L305, 5-oxo-L-proline; L446, choline; L465, D-asparagine; L496, dihydrolysergic acid amide; L893, sarcosine; L949, tryptophan; G83, alanine; G453, D-galactose; S134, 2-methyl-5-isopropenylfuran; S193, trans-dimethylaminocinnamonitrile; S204,2,2,4,4-tetramethyloctane; S205, 2,3-Dimethyl maleic anhydride
Fig. 6Profiling the difference between bioaugmentation by F4 and control sample (CN). a radar map of quality traits; b score plot of PCA based on the relative content of volatile components; c heat map of DCs-related flavor; d analysis of enzyme activity of strain F4